BMJ 1995;310:164 (21 January)

Papers

Why patients choose paracetamol for self poisoning and their knowledge of its dangers

Keith Hawton, senior clinical lecturer,a Christopher Ware, senior registrar,a Hamant Mistry, general practitioner trainee,b Jonathan Hewitt, registrar,b Stephen Kingsbury, clinical lecturer,a Dave Roberts, clinical nurse specialist,b Heather Weitzel, clinical nurse specialist b

a University Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX, b Barnes Unit, Department of Psychological Medicine, John Radcliffe Hospital, Oxford OX3 9DX

Correspondence to: Dr Hawton.

Paracetamol is the most commonly used substance in deliberate self poisoning.1 As a result, hepatic toxicity due to paracetamol accounts for over half of all cases referred to liver units because of fulminant liver failure,2 is the definite cause of at least 150 deaths a year in the United Kingdom3 and is now an important reason for liver transplanation.4

The reasons why people choose paracetamol for self poisoning and their understanding of its effects have been little studied. Nearly 20 years ago a study of patients with self poisoning by paracetamol admitted to London's King's College Hospital--a tertiary referral centre for patients with liver problems--showed that most patients did not know that paracetamol was dangerous in overdose.5 That study was conducted when self poisoning with paracetamol was much less common than it is now and before there had been much publicity about the phenomenon. We conducted the present study to determine why current patients with self poisoning by paracetamol choose paracetamol and their awareness of its dangers.

Subjects, methods, and results

In all, 80 patients out of a consecutive sample of 123 patients with self poisoning who were admitted to the John Radcliffe Hospital, Oxford, from September 1992 to March 1993 having taken overdoses of paracetamol or compounds containing paracetamol or both, consented to participate in the research interview. The subjects comprised more females than males, and most were fairly young (table). Of the remaining 43 patients, 18 refused to participate, 20 had left hospital before their consent could be obtained, and five were not invited because they were confused or too ill. No significant differences existed between the included and excluded patients according to sex and age. The interviewers were all experienced in interviewing patients with self poisoning. The interview was based on a structured questionnaire.


Details of 80 subjects with self
poisoning by paracetamol, their
reasons for choosing
paracetamol, and effects they
thought could result from
paracetamol overdose
---------------------------------------
                                No of
                              subjects
---------------------------------------
Sex:
  Female                         53
  Male                           27
Age (years):
  13-20                          32
  21-35                          32
  >/=36                          16
Reasons for choosing
  paracetamol*:
  Available                      50
  Dangerous                      29
  Cheap                           4
  Subject was uncertain           3
Anticipated effects of
  paracetamol overdose*:
  Completely safe                 0
  Mild, short lived effects       2
  Harmful but short
    lasting effects               8
  Permanent damage or
    harm                         16
  Could cause death              62
  Not known                       6
---------------------------------------
*More than one option could be
chosen.

Availability was the most common reason for subjects choosing paracetamol for their overdoses, although more than a third said they chose it because they knew it was dangerous (table). Although 38 subjects had taken an overdose with paracetamol that they had obtained for medical purposes, 42 had obtained the drug specifically for an overdose. When the subjects were asked to choose which of six possible outcomes of a paracetamol overdose they had expected, few thought that an overdose was safe, and more than three quarters thought that it could cause death. Thirty four subjects knew that paracetamol could cause damage to or failure of the liver. Most subjects, however, said that they thought that any harmful effects would have shown fairly quickly; only 18 realised that the effects would take more than 24 hours to appear. Responses to an open question about the specific effects of paracetamol showed that 42 subjects had expected paracetamol to cause unconsciousness.

Comment

The fact that paracetamol is dangerous in overdose seemed well recognised among our subjects, in contrast with the findings of the earlier study at King's College Hospital.5 This difference presumably reflects extensive media information about self poisoning with paracetamol and awareness of deaths resulting from overdose. Our study showed, however, a lack of knowledge about the specific effects that an overdose might have and the timing of such effects.

Prevention of fatal self poisoning with paracetamol is now an urgent issue. While education about the potential effects might be one approach, the considerable awareness of the dangers had clearly not put our subjects off. Reducing the number of tablets in individual preparations (with only one preparation allowed per purchase) seems to be a potentially more useful step.

This study was supported by a grant from Oxford Regional Health Authority. We thank Ann Day and Joan Fagg for helping to analyse the results and Dr Louise Sell and the staff at the Barnes Unit, Department of Psychological Medicine, John Radcliffe Hospital, for their help.

  1. Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976-90. BMJ 1992;304:1409-11.
  2. Bray GP. Liver failure induced by paracetamol. BMJ 1993;306:157-8.
  3. Spooner JB, Harvey JG. Paracetamol overdosage--facts not misconceptions. Pharm J 1993;250:706-7.
  4. O'Grady JG, Wendon J, Tan KC, Potter D, Cottam S, Cohen AT, et al. Liver transplantation after paracetamol overdose. BMJ 1991;303:221-3.
  5. Gazzard BG, Davis M, Spooner J, Williams R. Why do people use paracetamol for suicide? BMJ 1976;i:212-3.
(Accepted 23 November 1994)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Paracetamol and self poisoning
John B Spooner
BMJ 1995 310: 1072. [Extract] [Full Text]

This article has been cited by other articles:

  • Verma, S, Kaplowitz, N (2009). Diagnosis, management and prevention of drug-induced liver injury. Gut 58: 1555-1564 [Abstract] [Full text]  
  • Lee, H-L, Lin, H-J, Yeh, S.-Y, Chi, C-H, Guo, H-R (2008). Etiology and outcome of patients presenting for poisoning to the emergency department in Taiwan: a prospective study. Hum Exp Toxicol 27: 373-379 [Abstract]  
  • Rafnsson, S B, Oliver, J J, Elton, R A, Bateman, D N (2007). Poisons admissions in Edinburgh 1981-2001: agent trends and predictors of hospital readmissions. Hum Exp Toxicol 26: 49-57 [Abstract]  
  • Simkin, S., Hawton, K., Sutton, L., Gunnell, D., Bennewith, O., Kapur, N. (2005). Co-proxamol and suicide: preventing the continuing toll of overdose deaths. QJM 98: 159-170 [Abstract] [Full text]  
  • Hawton, K., Simkin, S., Deeks, J., Cooper, J., Johnston, A., Waters, K., Arundel, M., Bernal, W., Gunson, B., Hudson, M., Suri, D., Simpson, K. (2004). UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 329: 1076- [Abstract] [Full text]  
  • Staikowsky, F., Theil, F., Mercadier, P., Candella, S., Benais, J. P. (2004). Change in profile of acute self drug-poisonings over a 10-year period. Hum Exp Toxicol 23: 507-511 [Abstract]  
  • Hawton, K., Simkin, S., Deeks, J. (2003). Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings. BMJ 326: 1006-1008 [Abstract] [Full text]  
  • SHEEN, C.L., DILLON, J.F., BATEMAN, D.N., SIMPSON, K.J., MACDONALD, T.M. (2002). Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM 95: 609-619 [Abstract] [Full text]  
  • Hawton, K., Townsend, E., Deeks, J., Appleby, L., Gunnell, D., Bennewith, O., Cooper, J. (2001). Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ 322: 1203-1203 [Abstract] [Full text]  
  • Sheen, C L, MacDonald, T M, Thomas, M. R, Jowett, N. I, Law, R. (2001). Severity of overdose after restriction of paracetamol availability. BMJ 322: 553-553 [Full text]  
  • (1998). Proceedings of the British Toxicology Society Annual Congress University of Surrey, Guildford 19 - 22 April 1998. Hum Exp Toxicol 17: 469-534  
  • PEREIRA, S P, WILLIAMS, R (1998). Limits to liver transplantation in the UK. Gut 42: 883-885 [Full text]  
  • Nasir, A. K., Walburn, J. (1997). Poisoning With Acetaminophen "Jello". Pediatrics 99: 652-652 [Full text]  
  • Taylor, S. J, O'Connell, S., Pounder, D. J, McAllister, P., Spender, Q. (1997). Reducing paracetamol overdoses. BMJ 314: 750-750 [Full text]  
  • Fagan, E., Wannan, G. (1996). Reducing paracetamol overdoses. BMJ 313: 1417-1418 [Full text]  
  • Spooner, J. B (1995). Paracetamol and self poisoning. BMJ 310: 1072c-1072 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ